Journey Medical Corporation (DERM) Discounted Future Market Cap - Discounting Cash Flows
Journey Medical Corporation
DERM (NASDAQ)

Estimated Value

USD

Market Price USD

* Values are not guaranteed, please do your own
research before making investment decisions.

Discounted Future Market Cap

This model estimates the intrinsic value of a common share by projecting the Future Market Capitalization using the estimated PE Ratio and then discounting it to the Present using an Annual Required Rate of Return.

Interactive Assumptions

Results

Present Value 4.87 Thou. USD
Estimated net income -9.15 Bil. USD
Estimated market capitalization 162.8 Bil. USD
Market capitalization discounted to present 110.2 Bil. USD
Shares Outstanding 22.61 Mil.
Earnings Per Share (EPS) -0.396 USD
Market Price 7.04 USD
Price to Earnings (PE) Ratio -19.17

Historical and forecasted data

In Millions of USD

Edit Chart Values 2025 2026 2027 2028 2029

amounts of USD except for #

2024 LTM 2025 2026 2027 2028 2029
Revenue 56.13 56.24 84.61 162.2 311 596.2 1,143
Revenue Growth Rate -29.11% 0.194% 50.73% 91.72% 91.72% 91.72% 91.72%
Net Income -14.67 -8.3 -677.1 -1,298 -2,489 -4,772 -9,148

amounts of USD except for #

Average LTM 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015
Revenue 44.05 56.24 56.13 79.18 73.67 63.13 44.53 34.92 42.34 4.54 22.59 7.3
Cost of Revenue 19.44 18.85 20.88 26.66 30.77 32.08 14.59 10.53 1.18 0 0 0
Gross Profit 29.91 37.39 35.26 52.52 42.89 31.05 29.94 24.39 41.16 4.54 22.59 7.3
Gross Margin 76.12% 66.48% 62.81% 66.33% 58.23% 49.18% 67.23% 69.84% 97.22% 100% 100% 100%
Operating Income -67.92 -6.91 -13.68 -2.07 -27.52 -25.34 7.85 5.26 -214 -300.3 -90.62 -79.77
Operating Margin -790.7% -12.29% -24.36% -2.62% -37.35% -40.14% 17.63% 15.06% -505.4% -6,614% -401.3% -1,093%
Net Income -71.26 -8.3 -14.67 -3.85 -29.63 -43.99 5.28 3.62 -221.5 -303.3 -89.08 -78.4
Net Margin -800.3% -14.76% -26.14% -4.87% -40.22% -69.68% 11.86% 10.38% -523.3% -6,678% -394.4% -1,074%

amounts of USD except for #

Average LTM 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015
Revenue 44.05 56.24 56.13 79.18 73.67 63.13 44.53 34.92 42.34 4.54 22.59 7.3
Revenue Growth Rate 100.9% 0.194% -29.11% 7.48% 16.69% 41.78% 27.52% -17.52% 832.4% -79.89% 209.4% 0%
Net Income -71.26 -8.3 -14.67 -3.85 -29.63 -43.99 5.28 3.62 -221.5 -303.3 -89.08 -78.4
Net Margin -800.3% -14.76% -26.14% -4.87% -40.22% -69.68% 11.86% 10.38% -523.3% -6,678% -394.4% -1,074%
Net Income Growth Rate -45.25% -43.41% 280.8% -87% -32.65% -932.7% 45.74% -101.6% -26.95% 240.4% 13.63% 146%
Stockholders Equity 64.32 21.54 20.07 20.35 16.98 42.04 10.29 2.75 -9.04 149.6 247.4 185.5
Equity Growth Rate 29.72% 7.33% -1.38% 19.83% -59.61% 308.5% 274% -130.4% -106% -39.5% 33.37% 20.77%
Return on Invested Capital (ROIC) -10.88% -29.41% -55.47% -29.16% -436% 773.4% 37.17% 46.68% -106.5% -191.5% -39.76% -89.13%
After-tax Operating Income -69.03 -6.96 -13.73 -2.2 -27.58 -26.32 5.8 3.81 -213.8 -305.5 -93.76 -79.14
Income Tax Rate 3.46% -0.74% -0.417% -6.08% -0.213% -3.86% 26.14% 27.56% 0.087% -1.72% -3.46% 0.787%
Invested Capital 69.78 23.67 24.76 7.54 6.33 -3.4 15.6 8.16 200.8 159.5 235.8 88.79
discounting cash flows home logo

Discounting Cash Flows

Are you finding our services helpful? Review us on trustpilot logo Trustpilot
Have a question? Contact us